These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 27847912)

  • 21. Testosterone replacement therapy and prostate cancer: a word of caution.
    Brand TC; Canby-Hagino E; Thompson IM
    Curr Urol Rep; 2007 May; 8(3):185-9. PubMed ID: 17459266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testosterone therapy in men with testosterone deficiency: are the benefits and cardiovascular risks real or imagined?
    Traish AM
    Am J Physiol Regul Integr Comp Physiol; 2016 Sep; 311(3):R566-73. PubMed ID: 27488887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Testosterone replacement therapy and prostate cancer: the downfall of a paradigm?].
    Castillo OA; López-Fontana G; Vidal-Mora I; López Laur JD
    Medwave; 2015 Apr; 15(3):e6115. PubMed ID: 25919660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypogonadism: Therapeutic Risks, Benefits, and Outcomes.
    Sigalos JT; Pastuszak AW; Khera M
    Med Clin North Am; 2018 Mar; 102(2):361-372. PubMed ID: 29406064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testosterone and prostate cancer: what are the risks for middle-aged men?
    Morgentaler A
    Urol Clin North Am; 2011 May; 38(2):119-24. PubMed ID: 21621078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate cancer: Testosterone therapy for hypogonadal men with prostate cancer.
    Catarinicchia SP; Crawford ED
    Nat Rev Urol; 2016 Sep; 13(9):497-8. PubMed ID: 27431338
    [No Abstract]   [Full Text] [Related]  

  • 27. [When is testosterone substitution a medically necessary treatment?].
    Hakimi R
    Versicherungsmedizin; 2012 Jun; 64(2):74-7. PubMed ID: 22808644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypogonadism and Testosterone Therapy: Associations With Cardiovascular Risk.
    Maganty A; Osterberg EC; Ramasamy R
    Am J Mens Health; 2015 Jul; 9(4):340-4. PubMed ID: 24972716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate Risk and Monitoring During Testosterone Replacement Therapy.
    Bhasin S; Thompson IM
    J Clin Endocrinol Metab; 2024 Jul; 109(8):1975-1983. PubMed ID: 38753865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Overview of Testosterone Therapy.
    Lee OD; Tillman K
    Am J Mens Health; 2016 Jan; 10(1):68-72. PubMed ID: 25398416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testosterone therapy in hypogonadal patients and the associated risks of cardiovascular events.
    Kharaba ZJ; Buabeid MA; Ibrahim NA; Jirjees FJ; Obaidi HJA; Kaddaha A; Khajehkarimoddini L; Alfoteih Y
    Biomed Pharmacother; 2020 Sep; 129():110423. PubMed ID: 32570122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The dark side of testosterone deficiency: III. Cardiovascular disease.
    Traish AM; Saad F; Feeley RJ; Guay A
    J Androl; 2009; 30(5):477-94. PubMed ID: 19342698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risks of testosterone replacement therapy in ageing men.
    Tan RS; Salazar JA
    Expert Opin Drug Saf; 2004 Nov; 3(6):599-606. PubMed ID: 15500418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benefits and risks of testosterone therapy in older men.
    Cardona Attard C; Fava S
    Minerva Urol Nefrol; 2019 Jun; 71(3):217-229. PubMed ID: 30700083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?
    Gould DC; Kirby RS
    Prostate Cancer Prostatic Dis; 2006; 9(1):14-8. PubMed ID: 16264770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prostate carcinoma and testosterone: risks and controversies].
    Rhoden EL; Averbeck MA
    Arq Bras Endocrinol Metabol; 2009 Nov; 53(8):956-62. PubMed ID: 20126847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and Treatment of Testosterone Deficiency: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).
    Khera M; Adaikan G; Buvat J; Carrier S; El-Meliegy A; Hatzimouratidis K; McCullough A; Morgentaler A; Torres LO; Salonia A
    J Sex Med; 2016 Dec; 13(12):1787-1804. PubMed ID: 27914560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risks of testosterone-replacement therapy and recommendations for monitoring.
    Rhoden EL; Morgentaler A
    N Engl J Med; 2004 Jan; 350(5):482-92. PubMed ID: 14749457
    [No Abstract]   [Full Text] [Related]  

  • 39. Testosterone deficiency: myth, facts, and controversy.
    Miner M; Barkin J; Rosenberg MT
    Can J Urol; 2014 Jun; 21 Suppl 2():39-54. PubMed ID: 24978631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Androgen deficiency in aging and metabolically challenged men.
    Shelton JB; Rajfer J
    Urol Clin North Am; 2012 Feb; 39(1):63-75. PubMed ID: 22118346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.